Cargando…

SUN-452 Predictive Factors of Recurrence in Cushing's Disease after Successful Transsphenoidal Surgery

Introduction: Successful long-term management in Cushing’s disease (CD) is challenging. Transsphenoidal surgery (TS) is the treatment of choice. Recurrence rates vary from 15–66% within 5-10 years of initially successful surgery. Objective: To evaluate the predictive factors for recurrence in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Vânia, Gomes, Ana, Ferreira, Florbela, Bugalho, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553263/ http://dx.doi.org/10.1210/js.2019-SUN-452

Ejemplares similares

SAT-452 Results from the Phase 3 Multicenter SONICS Study of Levoketoconazole: Subgroup Analysis of Cushing's Syndrome (CS) Patients with Diabetes Mellitus (DM)
por: Fleseriu, Maria, et al.
Publicado: (2019)

SUN-453 Absence of Crooke's Hyaline Changes May Predict Worse Outcomes in Patients with Cushing Disease
por: Akirov, Amit, et al.
Publicado: (2019)

FRI346 Can We Miss Panhypopituitarism After Transsphenoidal Surgery?
por: Makawi, Alladdin, et al.
Publicado: (2023)

SAT-271 Block and Replace Therapy Successfully Improved Symptoms in Recurrent Cyclic Cushing’s Disease
por: Kamigaki, Risa, et al.
Publicado: (2020)

SUN-450 Comorbidities in 419 Patients with Cushing's Disease in Remission: A Swedish Nationwide Study
por: Papakokkinou, Eleni, et al.
Publicado: (2019)

SUN-305 Hair Cortisol Measurement: An Innovative Method for Diagnosis and Follow-Up in Patients with Cushing’s Disease
por: Deligiannis, Natalia Gabriela, et al.
Publicado: (2020)

Early Moderate Fluid Restriction and the Risk of Delayed Hyponatremia Following Transsphenoidal Surgery
por: Blount, Sydney L, et al.
Publicado: (2021)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients with Cushing's Disease
por: Savage, Martin, et al.
Publicado: (2019)

SUN-462 Petrous Sinus Catheterization, Baseline and after Stimulation with Desmopressin, for the Diagnosis of Cushing's Disease, Experience of a National Health Institute in Mexico
por: León-Suárez, Andrés, et al.
Publicado: (2019)

ODP340 NOVEL THERAPY OSILODROSTAT AS AN OPTION FOR RECURRENT CUSHING'S DISEASE
por: Marin, Luis Madera, et al.
Publicado: (2022)

MON-312 The Effects of Cabergoline in Pre-Surgical and Recurrence Periods of Cushing’s Disease Patients
por: Pereira, Ana Julia Garcia, et al.
Publicado: (2020)

SUN-LB074 Racial Distribution, Presentation and Outcome in Acromegaly and Cushing's Disease: A Tertiary Referral Center Study in 220 Patients
por: Goswami, Neevedita, et al.
Publicado: (2019)

OR23-03 Post-Operative Day One Morning Cortisol Value as a Biomarker to Predict the Recurrence of Cushing Disease
por: Wang, Fang, et al.
Publicado: (2020)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

SAT615 Long-term Effects Of Transsphenoidal Surgery On Headache In Patients With Pituitary Tumors - A Prospective Study
por: Hantelius, Victor, et al.
Publicado: (2023)

SAT-250 A Case of Late Recurrent Cushing’s Disease Presenting with Proximal Myopathy
por: Barsamyan, Gayane, et al.
Publicado: (2020)

Diagnostic Threshold for Postoperative Secondary Adrenal Insufficiency After Transsphenoidal Resection of Pituitary Adenomas
por: German, Massiell, et al.
Publicado: (2021)

MON-304 Prolactin as a Surrogate Marker to Predict Long Term Postoperative Hypopituitarism After Transsphenoidal Resection of Pituitary Adenomas
por: German, Massiell, et al.
Publicado: (2020)

MON-452 Development of Concepts for Improved Patient Care: What Do Patients with Acromegaly Expect from Their Caregivers?
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2019)

SUN-461 Predictors of Early and Late Hyponatremia after Pituitary Surgery
por: Cooper, Odelia, et al.
Publicado: (2019)

SAT-LB49 Persistent vs Recurrent Cushing’s Disease Diagnosed Four Weeks Post-Partum
por: Nosova, Emily V, et al.
Publicado: (2020)

SAT-256 The Ever Confusing Cushing’s Work Up: Is It Real? Is It Pseudo Cushing’s’? Or Could It Be Factitious
por: Ghalib, Luma, et al.
Publicado: (2020)

SUN-424 An Unusual Presentation of Delayed Onset Panhypopituitarism after Cardiac Surgery
por: O'Murchadha, Liam, et al.
Publicado: (2019)

SUN-423 Nonhemorrhagic Pituitary Apoplexy Following CABG Surgery
por: Aftab, Hassaan, et al.
Publicado: (2019)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Occult Carcinoid Causes Cushing’s Syndrome
por: Meftali, Sabrina, et al.
Publicado: (2021)

SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients with Cushing Syndrome (GRACE Study)
por: Auchus, Richard, et al.
Publicado: (2019)

SUN-428 Neurosarcoidosis: A Rare Cause of Hypothalamic-Pituitary Dysfunction
por: Ferreira, Ana, et al.
Publicado: (2019)

FRI299 Efficacy And Safety Of Endoscopic Transsphenoidal Resection For Prolactinoma: A Retrospective Case-series
por: Zandbergen, Ingrid M, et al.
Publicado: (2023)

SUN-289 Childhood-Onset, Adamantinomatous Craniopharyngioma and Successful Pregnancy: Results of Kraniopharyngeom 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2020)

PMON80 Case of Cushing's Disease That Presented as Diabetic Ketoacidosis and Successfully Treated With Stereotactic Radiosurgery During the COVID-19 Pandemic
por: Cadeliña, Jekrylei, et al.
Publicado: (2022)

THU021 Mysterious Resolution Of Cushing’s Disease
por: Whiteman, Daniel R, et al.
Publicado: (2023)

RF01 | PMON158 Does Early Moderate Fluid Restriction Decrease Incidence of Delayed Hyponatremia Following Transsphenoidal Surgery? A Randomized Prospective Trial
por: Fong, Brendan, et al.
Publicado: (2022)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

OR06-01 The Role of Germline Defects in Cushing’s Disease
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2020)

SAT-277 A Fierce Presentation of Cushing Disease
por: Al Sabie, Farah Laith, et al.
Publicado: (2020)

Antisense Oligonucleotides as a Novel Therapy for Cushing’s Disease
por: Eltumi, Hanan, et al.
Publicado: (2021)

MON-319 Impact of Tumor Characteristics and Preoperative IGF-1 Levels on Postoperative Hormonal Remission Following Endoscopic Transsphenoidal Surgery in Patients with Acromegaly: A Single-Surgeon Series
por: Cardinal, Tyler, et al.
Publicado: (2020)

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome
por: Simeoli, Chiara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mqenrj9bgttrjpuiig02n32ub7